These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15280933)

  • 1. Lung cancer management concerns in New Zealand.
    Garrett J
    N Z Med J; 2004 Jun; 117(1196):U929. PubMed ID: 15280933
    [No Abstract]   [Full Text] [Related]  

  • 2. Metastatic non-small cell lung cancer: costs associated with disease progression.
    Fox KM; Brooks JM; Kim J
    Am J Manag Care; 2008 Sep; 14(9):565-71. PubMed ID: 18778171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer management in limited resource settings: guidelines for appropriate good care.
    Macbeth FR; Abratt RP; Cho KH; Stephens RJ; Jeremic B;
    Radiother Oncol; 2007 Feb; 82(2):123-31. PubMed ID: 17239979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F; Tiseo M
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer treatment in New Zealand: physician's attitudes.
    Christmas T; Findlay M
    N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer cure, care, and cost: let the data be your guide.
    Kris MG
    J Clin Oncol; 1997 Sep; 15(9):3027-9. PubMed ID: 9294464
    [No Abstract]   [Full Text] [Related]  

  • 7. Costs and ethical issues related to first-line treatment of metastatic non-small-cell lung cancer: considerations from a public healthcare system perspective.
    Bosch-Barrera J; Quer N; Brunet J
    Clin Lung Cancer; 2011 Nov; 12(6):335-40. PubMed ID: 21816680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer.
    Lennes IT; Lynch TJ
    Clin Lung Cancer; 2009 Sep; 10(5):341-6. PubMed ID: 19808192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations.
    Stevens W; Stevens G; Kolbe J; Cox B
    Intern Med J; 2008 Oct; 38(10):758-68. PubMed ID: 18298555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the care of lung cancer patients: a multidisciplinary approach.
    Gradishar WJ; Bitran JD
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1023-5. PubMed ID: 1962773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic strategies in non-small-cell lung carcinoma: how to optimize patient management?].
    Fournel P
    Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S23-30. PubMed ID: 16273007
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands.
    Pompen M; Gok M; Novák A; van Wuijtswinkel R; Biesma B; Schramel F; Stigt J; Smit H; Postmus P
    Lung Cancer; 2009 Apr; 64(1):110-6. PubMed ID: 18805601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in the management of stage IIIA non-small-cell lung cancer.
    Santos ES; Castrellon A; Blaya M; Raez LE
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1913-29. PubMed ID: 19046112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
    Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
    Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of advanced non-small-cell lung cancer (take home message).
    Pirker R
    Lung Cancer; 2004 Aug; 45 Suppl 2():S259-62. PubMed ID: 15552808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the pattern of care for lung cancer and their correlation with new clinical evidence: experiences in a university-affiliated medical center.
    Chien CR; Lai MS
    Am J Med Qual; 2006; 21(6):408-14. PubMed ID: 17077423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of multidisciplinary lung cancer practice.
    Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
    Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapies for non-small cell lung cancer: introduction.
    D'Amico TA
    Semin Thorac Cardiovasc Surg; 2005; 17(3):179. PubMed ID: 16253818
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing patients with lung cancer. Common international guidelines must be developed.
    Ardizzoni A; Grossi F; Salvati F; Silvano G; Santi L
    BMJ; 2000 Feb; 320(7231):380. PubMed ID: 10712030
    [No Abstract]   [Full Text] [Related]  

  • 20. Lung cancer.
    Neville A
    Clin Evid; 2005 Dec; (14):1903-20. PubMed ID: 16620475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.